| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Biotechnology (Health Care sector), REVB's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 422.8K | - | - | |
| Dir | 44.8K | - | - | |
| Dir | 44.8K | - | - | |
| Dir | 44.2K | - | - | |
| CFO | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 9, 2020 | Glazer Capital, LLC69 | 10% Owner | Sell | 5,000 | $10.00 | $50,000.00 | -0.5% | |
| Oct 12, 2020 | Glazer Capital, LLC69 | 10% Owner | Sell | 9,348 | $10.00 | $93,480.00 | -0.9% |